Form 4: Vivani Medical Director Acquires Stock Options in Lieu of Cash Retainer
SEC Form 4
Director Gregg Williams acquired 76,757 stock options in Vivani Medical, Inc. in lieu of a $69,000 cash retainer.
Summary
- Gregg Williams, a director of Vivani Medical, Inc., acquired 76,757 non-qualified stock options on January 1, 2025.
- These options were granted in lieu of a $69,000 cash retainer fee, as part of the company's non-employee director compensation policy.
- The options have an exercise price of $1.16 per share and a 10-year term, expiring on December 31, 2034.
- The options vest quarterly through December 31, 2025, subject to continued service as a director.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, indicating a positive alignment of interests between the director and the company. There are no negative implications.
Positives
- The use of stock options in lieu of cash may conserve company cash resources.
- The vesting schedule of the options aligns the director's interests with the long-term performance of the company.
Risks
- The value of the stock options is dependent on the future performance of Vivani Medical's stock price.
- If the stock price does not increase above the exercise price, the options may not be valuable to the director.
Industry Context
The use of stock options as part of director compensation is a common practice in the biotechnology industry, aligning director interests with company performance and conserving cash.
Comparison to Industry Standards
- Many biotechnology companies use stock options as part of their compensation packages for directors and executives.
- The vesting schedule and term of the options are within typical ranges for similar companies.
- The value of the options is dependent on the company's stock performance, which is a standard practice in the industry.
Stakeholder Impact
- Shareholders may view the use of stock options as a positive sign of aligning director interests with company performance.
- Employees may see this as a standard practice for director compensation.
Key Dates
| Date | Description |
|---|---|
| 01/01/2025 | Date of the stock option grant. |
| 12/31/2025 | End of the vesting period for the stock options. |
| 12/31/2034 | Expiration date of the stock options. |
| 01/03/2025 | Date the form was signed. |
Keywords
stock options, director compensation, non-qualified stock options, Vivani Medical, VANI, equity, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.